CEO's On the Move

Ben Ward, Chief Executive Officer of Maricann Group Inc., Taken a Leave of Absence Until November 13, 2017
10/20/2017
Maricann Group Inc. (undefined:Canadian Securities Exchange) Maricann Group Inc. announced that Mr. Ben Ward, its Chief Executive Officer, has taken a leave of absence until November 13, 2017, to address a personal health issue. Mr. Terry Fretz, the company's President, has assumed the duties that Mr. Ward is not able to perform on an interim basis, through the ...

Upcoming Board Meetings

China Overseas Land & Investment Limited
(688:HK:Stock Exchange of Hong Kong Limited)
October 20, 2017
China Overseas Land & Investment Limited, Board Meeting, Oct 20, 2017. Agenda: To consider and approve financial and business review for the third quarter of 2017.
Announced 09/27/17
China Overseas Land & Investment Limited Key Board Members
Jianguo Yan
Chairman & Chief Executive Officer
Wenjie Sun
Honourable Chairman
Yun Wing Nip
CFO & Executive Director

Executive Changes

S.N.G.N. RomGaz S.A. Announces Directorate Change
10/20/17
S.N.G.N. Romgaz S.A. Board of Directors, adjourned in the meeting of October 19, 2017: took note of Mr. Gheorghe Gheorghe - Gabriel resignation as Chairman of the Board of Directors and as member of S.N.G.N. Romgaz S.A. Board of Directors; elected Mr. Nistoran Dorin-Liviu, as Chairman of the Board of Directors, on the vacant position as a result of Mr. Gheorghe Gheorghe - Gabriel resignation.
Medigard Ltd Announces Executive Changes
10/20/17
The Board of Medigard Ltd. (MGZ) advised that Mr. Don Channer has retired as Chairman of the company and welcomed Dr. Chris Bishop as the Chairman. The retirement and appointment is effective from the Board meeting 20 October 2017. Mr. Channer considers that now is an appropriate time to retire as Medigard Ltd. moves towards its next phase. He will remain as a non-executive Director of the company. Dr. Bishop has been a non-executive Director of Medigard Ltd. since 2008. He has extensive experience in the development and commercialization of a range of technologies.
Helios Energy Ltd Announces Resignation of Carl Coward as Director
10/20/17
The Board of Directors of Helios Energy Ltd. announced that Carl Coward has resigned as a director.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Top Compensated Executives at undefined

Name/TitleAnnual Compensation
There is no Top Compensated Executives data available.

Average Compensation in the Pharmaceuticals Industry

Pharmaceuticals
$525.3K
Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.